Actively Recruiting
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Led by Paradigm Biopharmaceuticals Ltd. · Updated on 2026-05-08
466
Participants Needed
56
Research Sites
109 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.
CONDITIONS
Official Title
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant must be 18 years of age or older at the time of signing informed consent.
- Clinical diagnosis of knee osteoarthritis by American College of Rheumatology 1986 criteria.
- Radiographic confirmation of knee osteoarthritis with Kellgren-Lawrence grade 2, 3, or 4.
- Unresponsive to at least two types of osteoarthritis treatments in the past 12 months or unable to tolerate NSAIDs.
- Average daily knee pain score between 4 and 9 on the numerical rating scale at screening.
- Baseline weekly average knee pain score between 4 and 9 in the 7 days before randomization.
- No more than one daily pain score of 10 in the 7 days before Day 1.
- Body mass index between 18.0 and 39.0 kg/m2.
- Women of childbearing potential and men agree to use specified contraceptive methods.
- Able to give informed consent and comply with study requirements.
- Completion of at least 11 out of 14 daily pain scores during the 14 days before randomization.
- Stable non-pharmacologic knee osteoarthritis treatment for at least 2 weeks before Day 1 and willingness to maintain it.
- Willing to stop oral and topical NSAIDs and systemic pain medications (except allowed rescue medication) from 2 weeks before Day 1 until study end.
- Agree to use acetaminophen or topical analgesics (not topical NSAIDs) as rescue therapy if needed.
You will not qualify if you...
- History of idiopathic or immune-mediated thrombocytopenia or heparin-induced thrombocytopenia.
- History of major bleeding disorders such as haemophilia.
- Active or recent (past 12 months) gastric or duodenal ulcers or gastrointestinal bleeding.
- Recent cerebral bleeding or surgery on brain, spine, or eyes within 12 months.
- Spinal anesthesia within 14 days before Day 1.
- Fibromyalgia, lumbar or cervical radiculopathy, or other severe pain disorders that affect pain assessment.
- Current sciatica or recent symptomatic sciatica within 3 months.
- Other diseases affecting the index knee like rheumatoid arthritis, gout, lupus, infections, or tumors.
- Allergy to PPS, heparin, or related drugs.
- Multiple severe allergies or atopic diseases.
- Allergy to tetracosactide, cosyntropin, or gadolinium.
- Unstable or poorly controlled chronic medical conditions requiring recent changes.
- History of pituitary irradiation or recent pituitary surgery.
- Cancer within past 5 years except basal cell carcinoma.
- Autoimmune polyglandular syndromes.
- Any condition likely to prevent compliance or completion of the study.
- Use of anticoagulants or antiplatelet drugs (except low-dose aspirin) within 2 weeks before Day 1.
- Previous treatment with PPS.
- Recent immunosuppressive or corticosteroid therapy within specified timeframes.
- Use of NSAIDs, opioids, glucosamine, chondroitin, bisphosphonates, denosumab, iloprost, or cannabinoids within specified windows before Day 1.
- Use of knee brace within 2 weeks before Day 1.
- Recent intra-articular injections within specified periods.
- Use of vitamins or supplements known to affect blood clotting within 2 weeks before Day 1.
- Exposure to heparin within last 100 days.
- Use of certain hormonal or steroid treatments within specified timeframes.
- Participation in another clinical trial within 24 weeks before Day 1.
- Abnormal lab results or vital signs including blood pressure outside specified ranges.
- Eye conditions or macular abnormalities affecting vision.
- Low morning cortisol or ACTH levels.
- Hyperkalaemia or hyponatremia.
- Contraindications to MRI.
- Severe physical incapacitation.
- Recent or planned major surgery or hospitalization.
- Planned total knee reconstruction during study.
- Knee surgery or trauma within 1 year before Day 1.
- Recent history of drug or alcohol abuse affecting compliance.
- Employment or close relation to study personnel or sponsor.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 56 locations
1
Onyx Clinical Research-Peoria
Peoria, Arizona, United States, 85381
Actively Recruiting
2
Del Sol Research Management, LLC
Tucson, Arizona, United States, 85715
Actively Recruiting
3
Orange County Research Institute
Anaheim, California, United States, 92801
Actively Recruiting
4
Core Healthcare Group
Cerritos, California, United States, 90703
Actively Recruiting
5
Triwest Research Center
Chula Vista, California, United States, 91910
Actively Recruiting
6
Seaside Medical Group
Oceanside, California, United States, 92058
Actively Recruiting
7
Paragon RX Clinical
Santa Ana, California, United States, 92703
Actively Recruiting
8
Encompass Clinical Research
Spring Valley, California, United States, 91978
Actively Recruiting
9
Focus Clinical Research
West Hills, California, United States, 91307
Actively Recruiting
10
Clinical Research of West Florida - Clearwater
Clearwater, Florida, United States, 33765
Actively Recruiting
11
GNP Research
Cooper City, Florida, United States, 33024
Actively Recruiting
12
Arrow Clinical Trials
Daytona Beach, Florida, United States, 32117
Actively Recruiting
13
AGA Clinical Trials
Hialeah, Florida, United States, 33012
Actively Recruiting
14
Evolution Clinical Trials
Miami, Florida, United States, 33122
Actively Recruiting
15
Well Pharma Medical Research
Miami, Florida, United States, 33173
Actively Recruiting
16
K2 Medical Research
Orlando, Florida, United States, 32806
Actively Recruiting
17
Progressive Medical Research
Port Orange, Florida, United States, 32127
Actively Recruiting
18
Phoenix Clinical Research
Tamarac, Florida, United States, 33321
Actively Recruiting
19
Conquest Research
Winter Park, Florida, United States, 32789
Actively Recruiting
20
Chicago Clinical Research, Inc
Chicago, Illinois, United States, 60607
Actively Recruiting
21
Northwestern University
Chicago, Illinois, United States, 60611
Actively Recruiting
22
Sinai Hospital of Baltimore
Baltimore, Maryland, United States, 21215
Actively Recruiting
23
Profound Research
Farmington Hills, Michigan, United States, 48334
Actively Recruiting
24
Insight Research Institute
Flint, Michigan, United States, 48507
Actively Recruiting
25
Rochester Medical Group
Rochester Hills, Michigan, United States, 48307
Actively Recruiting
26
Onyx Clinical Research - Rochester Hills
Troy, Michigan, United States, 48085
Actively Recruiting
27
Physician Research Collaboration
Lincoln, Nebraska, United States, 68516
Actively Recruiting
28
Alpine Healthcare Family Practice
Las Vegas, Nevada, United States, 89109
Actively Recruiting
29
Drug Trials America
Hartsdale, New York, United States, 10530
Actively Recruiting
30
Groth Pain & Spine - Long Island, NY
Mineola, New York, United States, 11501
Actively Recruiting
31
IMA Clinical Research Manhattan
New York, New York, United States, 10036
Actively Recruiting
32
Groth Pain and Spine Management
Smithtown, New York, United States, 11787
Actively Recruiting
33
FutureSearch Trials of Neurology
Austin, Texas, United States, 78731
Actively Recruiting
34
FutureSearch Trials of Dallas
Dallas, Texas, United States, 75251
Actively Recruiting
35
Vilo Research Group
Houston, Texas, United States, 77017
Actively Recruiting
36
DM Clinical Research
Houston, Texas, United States, 77065
Actively Recruiting
37
Clinical Trial Network
Houston, Texas, United States, 77074
Actively Recruiting
38
Epic Clinical Research
Lewisville, Texas, United States, 75057
Actively Recruiting
39
Quality Research Inc.
San Antonio, Texas, United States, 78209
Actively Recruiting
40
Rio Clinical Trials
Ogden, Utah, United States, 84404
Actively Recruiting
41
Canopy Clinical Research-Northern Beaches
Brookvale, New South Wales, Australia, 2100
Actively Recruiting
42
Novatrials
Charlestown, New South Wales, Australia, 2290
Actively Recruiting
43
Canopy Clinical Research - Sutherland Shire
Miranda, New South Wales, Australia, 2228
Actively Recruiting
44
Canopy Clinical Research-Wollongong
Wollongong, New South Wales, Australia, 2500
Actively Recruiting
45
Mater Health Brisbane
South Brisbane, Queensland, Australia, 4101
Actively Recruiting
46
Griffith University
Southport, Queensland, Australia, 4222
Actively Recruiting
47
Royal Adelaide Hospital
Adelaide, South Australia, Australia, 5000
Actively Recruiting
48
Sportsmed
Stepney, South Australia, Australia, 5069
Actively Recruiting
49
Canopy Clinical Research-Altona North
Altona N., Victoria, Australia, 3025
Actively Recruiting
50
Sportsmed Biologic LTD
Box Hill, Victoria, Australia, 3128
Actively Recruiting
51
Clinitrials
Perth, Western Australia, Australia, 6000
Actively Recruiting
52
RK Will Pty Ltd
Victoria Park, Western Australia, Australia, 6100
Actively Recruiting
53
Hong Kong Centre for Clinical Research
Hong Kong, Hong Kong
Actively Recruiting
54
PMSI "Timofei Mosneaga" Republican Clinical Hospital
Chisinau, Moldova, MD2025
Actively Recruiting
55
PMSI Institute of Cardiology
Chisinau, Moldova, MD2025
Actively Recruiting
56
PMSI "Sfanta Treime" Municipal Clinical Hospital
Chisinau, Moldova, MD2068
Actively Recruiting
Research Team
D
Donna Skerrett
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here